Mast Therapeutics (MSTX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts MSTX Hot Sheet
Join SI Premium – FREE
Mast Therapeutics (NYSE: MSTX) reported Q2 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- Cummins wins battery storage contract for U.S. data center project
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
